Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

David Metcalfe has been awarded both the prestigious Syme Medal and the AOUK&I Trauma Research Prize 2019 in recognition of his DPhil work in musculoskeletal science.

Horizontal portrait of David Metcalfe

Both awards recognised David's work undertaken as part of his NDORMS DPhil which he completed at the University of Oxford earlier this year. David delivered a number of studies that used routinely collected healthcare data to help clinicians provide better care for older adults with hip fractures. This work found widespread variation and even systematic inequalities in terms of the operations being offered to patients with broken hips. It also showed that the Hip Fracture Best Practice Tariff in England – which pays hospitals a supplement for providing high quality healthcare – improved quality of care and outcomes for these patients.

"These awards are important because they recognise the huge potential of data already collected by the NHS to improve patient care," said David.

The Syme Medal is awarded annually by The Royal College of Surgeons of Edinburgh for doctoral research that is "likely to influence clinical practice". The AOUK&I Trauma Research Prize is open to all surgeons in training for papers focused on any aspect of musculoskeletal trauma. David's DPhil research was funded by an Oxford-UCB Prize Fellowship.

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.